Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This target is a human pseudogene similar to the mouse gene “Myxovirus resistance 1 (MX1), interferon-inducible protein p78.” Unlike the protein-coding MX1 gene that encodes the antiviral MX1 protein, this pseudogene does not produce a functional protein and has no known biological activity or role in disease. It is sometimes mistakenly referenced when searching for the MX1 gene, which is important in innate immunity and antiviral defense, but they are distinct entities. This pseudogene is not used as a therapeutic target, has no known drug interactions, and has no role as a biomarker. Its classification as a pseudogene means it is considered a relic of evolution and does not participate in molecular pathways or cellular functions[1][5]. Important clarification: If structured, this entry should be flagged as “is_incorrect: true” to avoid confusion with the protein-coding MX1 gene. The MX1 gene encodes a dynamin-like GTPase crucial for host restriction of viruses, is induced by interferons, and is a well-established antiviral effector—none of which applies to this pseudogene[1][4][5][6][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Myxovirus resistance 1, interferon-inducible protein p78 (mouse) pseudogene.